P

Inventor

FORTUNAK JOSEPH M

US11 patents
⚠️ This page may combine multiple inventors who share the name “FORTUNAK JOSEPH M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DU PONT PHARM CO

6 patents
US6049019AApr 11, 2000

Process for the preparation of cyclopropylacetylene

DU PONT PHARM CO5 citations73
US6297410B1Oct 2, 2001

Process for the preparation of cyclopropylacetylene

DU PONT PHARM CO3 citations62
US6288297B1Sep 11, 2001

Process for the preparation of cyclopropylacetylene

DU PONT PHARM CO2 citations61
US6194569B1Feb 27, 2001

Efficient process for the preparation of [S-(R,S)]-N-[1,3-benzodioxol-5-yl)butyl]-3,3-diethyl-2[4-[4-methyl-1-piperazinyl)carbonyl]phenoxy]-4-oxo-1-azetidine carboxamide, a human leukocyte elastase inhibitor

DU PONT PHARM CO3 citations59
US6214847B1Apr 10, 2001

Crystalline 10,10-Bis((2-fluoro-4-pyridinyl)methyl)-9(10H)-Anthracenone and an improved process for preparing the same

DU PONT PHARM CO0 citations47
US6218534B1Apr 17, 2001

Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate

DU PONT PHARM CO0 citations45

SMITH KLINE FRENCH LAB

1 patent
US4997954AMar 5, 1991

Process for preparing substituted isoindolinone derivatives

SMITH KLINE FRENCH LAB12 citations71

SMITHKLINE BEECHAM CORP

1 patent
US5155225AOct 13, 1992

Method for making certain pyrano[3',4':6,7]indolizino-[1,2-B]quinolinones

SMITHKLINE BEECHAM CORP12 citations70

(unassigned)

1 patent
US6359164B1Mar 19, 2002

Process for the preparation of cyclopropylacetylene

1 citations51

BRISTOL MYERS SQUIBB PHARMA

1 patent
US6555686B2Apr 29, 2003

Asymmetric synthesis of quinazolin-2-ones useful as HIV reverse transcriptase inhibitors

BRISTOL MYERS SQUIBB PHARMA0 citations46

BRISTOL MYERS SQUIBB PHARMA CO

1 patent
US6452000B2Sep 17, 2002

Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate

BRISTOL MYERS SQUIBB PHARMA CO1 citations45